Related references
Note: Only part of the references are listed.Vaginal lubricants and moisturizers: a review into use, efficacy, and safety
N. Potter et al.
CLIMACTERIC (2021)
Physical methods for the treatment of genitourinary syndrome of menopause: A systematic review
Ayane C. A. Sarmento et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2021)
Hyaluronic Acid in Postmenopause Vaginal Atrophy: A Systematic Review
Carlos Campagnaro M. dos Santos et al.
JOURNAL OF SEXUAL MEDICINE (2021)
The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society
[Anonymous]
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2020)
Pharmacotherapy for the treatment of vaginal atrophy
Gilbert G. G. Donders et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Vaginal atrophy across the menopausal age: results from the ANGEL study
A. Cagnacci et al.
CLIMACTERIC (2019)
A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause
Colton Biehl et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2019)
A systematic review of laser therapy for vulvovaginal atrophy/genitourinary syndrome of menopause in breast cancer survivors
Charity Knight et al.
ECANCERMEDICALSCIENCE (2019)
Vaginal Health: Insights, Views & Attitudes (VIVA-LATAM): results from a survey in Latin America
R. E. Nappi et al.
CLIMACTERIC (2018)
Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health
Stephanie S. Faubion et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2018)
Genitourinary syndrome of menopause treatment using lasers and temperature-controlled radiofrequency
Jadwiga Wanczyk-Baszak et al.
MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY (2018)
Light and Energy Based Therapeutics for Genitourinary Syndrome of Menopause: Consensus and Controversies
Yona Tadir et al.
LASERS IN SURGERY AND MEDICINE (2017)
Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
D. Edwards et al.
CLIMACTERIC (2016)
2016 IMS Recommendations on women's midlife health and menopause hormone therapy
R. J. Baber et al.
CLIMACTERIC (2016)
Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society
David J. Portman et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2014)
Vaginal Estrogen for Genitourinary Syndrome of Menopause A Systematic Review
David D. Rahn et al.
OBSTETRICS AND GYNECOLOGY (2014)
Promestriene, a specific topic estrogen. Review of 40 years of vaginal atrophy treatment: is it safe even in cancer patients?
Lino Del Pup et al.
ANTI-CANCER DRUGS (2013)
Vulvar and Vaginal Atrophy in Postmenopausal Women: Findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) Survey
Sheryl A. Kingsberg et al.
JOURNAL OF SEXUAL MEDICINE (2013)
Oestrogen therapy for urinary incontinence in postmenopausal women
June D. Cody et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Minimized estradiol absorption with ultra-low-dose 10 μg 17β-estradiol vaginal tablets
M. Eugster-Hausmann et al.
CLIMACTERIC (2010)
Endometrial safety of ultra-low-dose Vagifem 10 mu g in postmenopausal women with vaginal atrophy
L. S. G. Ulrich et al.
CLIMACTERIC (2010)
Endometrial Safety of Ultra-Low-Dose Estradiol Vaginal Tablets
James Simon et al.
OBSTETRICS AND GYNECOLOGY (2010)
An ultra-low dose (10μg) estradiol vaginal tablet improves signs and symptoms associated with vaginal atrophy
L. Nachtigall et al.
FERTILITY AND STERILITY (2008)
Benefit and safety of 28-day transdermal estrogen regiment during vaginal hysterectomy (a controlled trial)
A Vesna et al.
MATURITAS (2006)